V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials
Open Access
- 14 December 2010
- Vol. 117 (11), 2478-2488
- https://doi.org/10.1002/cncr.25791
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?Journal of Clinical Oncology, 2010
- Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II StudyJournal of Clinical Oncology, 2009
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular CarcinomaJournal of Clinical Oncology, 2008
- Phase II Study of Sorafenib in Patients With Advanced Hepatocellular CarcinomaJournal of Clinical Oncology, 2006
- Clinical Significance of Angiogenesis in Gastrointestinal CancersAnnals of Surgery, 2003
- Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)The Esophagus, 2003
- Evaluating the yield of medical testsJAMA, 1982
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973